Active ingredientNilutamideCat. No. P-N064-001CAS 63612-50-0Family · Pharmaceutical analytical standards
Nilutamide
A non-steroidal antiandrogen that blocks the androgen receptor, discovered in 1977 and introduced in France in 1987 (in the United States in 1996) for metastatic prostate cancer, together with testosterone-suppressing therapy. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It is the only one of its class that can slow the eyes' adaptation to darkness, a mild and reversible effect; it was the second non-steroidal antiandrogen on the market, after flutamide.
Go to the active ingredient →Active ingredientNilutamideCat. No. P-N064-001CAS 63612-50-0
Isotopically labelledNilutamide-d6Cat. No. P-N064-002CAS 1189477-66-4
ImpurityNilutamide EP Impurity ACat. No. P-N064-003CAS 63612-49-7No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceNilutamide CRSEDQM code Y0000829Family Nilutamide
ImpurityNilutamide impurity B CRSEDQM code Y0000894Family NilutamideNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.